Literature DB >> 3308177

Pitfalls in the initial diagnosis of tyrosinemia: three case reports and a review of the literature.

K J Goulden1, M A Moss, D E Cole, G A Tithecott, J F Crocker.   

Abstract

The tyrosinemias are a complex and heterogeneous group of disorders in tyrosine catabolism that embrace a wide spectrum of clinical conditions, ranging from the benign neonatal variety to the severe hepatorenal form. Readily available diagnostic tests are too insensitive to distinguish between these variants, and more definitive but technically difficult tests can be performed rapidly in only a few centres. Effective management may therefore be compromised, due to the inability of obtaining a working diagnosis quickly. This report describes difficulties encountered with conventional testing in three patients. Analysis of whole blood delta-aminolevulinic acid dehydratase activity and determination of urinary inhibition activity against the enzyme were found to be rapid and reliable screening tests for hepatorenal or type I hereditary tyrosinemia. These procedures are recommended in the initial evaluation of undifferentiated tyrosinemic states.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308177     DOI: 10.1016/s0009-9120(87)80122-4

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Tyrosinaemia type I with normal levels of plasma tyrosine.

Authors:  I T de Almeida; P P Leandro; M F Silva; C Silveira; A da Silva; J S de Sousa; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Type I hereditary tyrosinaemia: presentation of 11 cases.

Authors:  T Coşkun; I Ozalp; N Koçak; A Yüce; M Caglar; R Berger
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Liver transplantation in nine Spanish patients with tyrosinaemia type I.

Authors:  C Pérez-Cerdá; B Merinero; P Sanz; M Castro; J Gangoiti; M J García; M Díaz; E Medina; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.

Authors:  Bijo Varughese; Dnyanoba Madrewar; Sunil Kumar Polipalli; Seema Kapoor
Journal:  Indian J Clin Biochem       Date:  2021-01-06

Review 5.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 6.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 7.  Newborn screening for Tyrosinemia type 1 using succinylacetone - a systematic review of test accuracy.

Authors:  Chris Stinton; Julia Geppert; Karoline Freeman; Aileen Clarke; Samantha Johnson; Hannah Fraser; Paul Sutcliffe; Sian Taylor-Phillips
Journal:  Orphanet J Rare Dis       Date:  2017-03-09       Impact factor: 4.123

8.  Inter-laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples.

Authors:  Hilde Laeremans; Charles Turner; Tommy Andersson; Jose Angel Cocho de Juan; Adam Gerrard; M Rebecca Heiner-Fokkema; Diran Herebian; Nils Janzen; Giancarlo la Marca; Mattias Rudebeck
Journal:  JIMD Rep       Date:  2020-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.